SenesTech Set for Lytham Partners Spring 2025 Investor Gathering on May 29, 2025
Phoenix-Based SenesTech to Present at Lytham Partners Spring 2025 Investor Conference
SenesTech, Inc., a leading innovator in fertility control solutions for rodent population management, has announced its participation in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025. The virtual event will be held exclusively online.
During the conference, SenesTech's team will deliver a webcast presentation at 3:30 p.m. Eastern Time. Interested parties can access the presentation through the conference homepage or the direct link provided. The presentation will also be available for replay following the event.
In addition to the webcast, SenesTech executives will participate in a fireside chat and one-on-one meetings with investors throughout the conference. To arrange a meeting, investors are encouraged to contact Lytham Partners via email.
Founded with a mission to humanely manage animal pest populations, SenesTech has developed multiple U.S. EPA-registered contraceptives for rodents, including ContraPest and Evolve. These contraceptives seamlessly integrate into all integrated pest management programs, enhancing overall effectiveness.
For more information about SenesTech and its products, visit their official website.
In a related matter, the company recently issued a safe harbor statement due to the inherent risks associated with the successful commercialization of its products, market acceptance, financial performance, regulatory compliance, and other factors. For detailed information on these risks, investors are urged to consult SenesTech's filings with the Securities and Exchange Commission.
Investor inquiries can be directed to Robert Blum of Lytham Partners, LLC, while SenesTech's Chief Financial Officer, Tom Chesterman, can be reached directly for company-specific inquires.
PRNewswire press release
SOURCE SenesTech, Inc.
About SenesTechSenesTech is a trailblazer in fertility control solutions for rodent population control, leveraging its expertise to develop proactive, safe, and sustainable products. Their flagship products, ContraPest and Evolve, are EPA-registered contraceptives for male and female rats, respectively. These products have been designed to be humane, effective, and sustainable, contributing to the goals of clean cities, efficient businesses, and content households. For more information, visit SenesTech's official website.
- SenesTech's team will present their performance in rodent population management solutions at the Lytham Partners Spring 2025 Investor Conference, discussing the effectiveness of their cloud-based rodent contraceptives ContraPest and Evolve.
- Investors interested in SenesTech's finance and business growth should arrange meetings with the company's executives during the conference, as they will address potential risks associated with the business, such as regulatory compliance and financial performance.
- To maintain transparency and ensure public disclosure, SenesTech issued a safe harbor statement addressing the inherent risks associated with the successful commercialization of their products, market acceptance, and other factors, encouraging investors to consult their filings with the Securities and Exchange Commission for detailed information.
